Prescribing information


Useful tools and resources for HCPs to share with patients who have been prescribed ▼Beovu® (brolucizumab) for the treatment of wet AMD.





This booklet contains information for patients about:

  • What is Beovu and why they have been prescribed it
  • What to expect from treatment with Beovu, including possible side effects
  • Their appointments and how to monitor their vision (including Amsler grid)
  • Where to find further information and support.




AMD, age-related macular degeneration; HCP, healthcare professional.

Rate this content: 
Average: 1 (1 vote)
BEO20-C039n September 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]